The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 16, 2019

Filed:

Apr. 21, 2017
Applicant:

Chrono Therapeutics Inc., Hayward, CA (US);

Inventors:

Guy DiPierro, San Francisco, CA (US);

Steven A. Giannos, Quincy, MA (US);

Assignee:

Chrono Therapeutics Inc., Hayward, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61M 35/00 (2006.01); A61M 5/142 (2006.01); A61K 31/135 (2006.01); A61K 31/17 (2006.01); A61K 31/192 (2006.01); A61K 31/27 (2006.01); A61K 31/4164 (2006.01); A61K 31/42 (2006.01); A61K 31/428 (2006.01); A61K 31/435 (2006.01); A61K 31/4436 (2006.01); A61K 31/445 (2006.01); A61K 31/47 (2006.01); A61K 31/498 (2006.01); A61K 31/505 (2006.01); A61K 31/55 (2006.01); A61K 31/704 (2006.01); A61M 37/00 (2006.01); A61N 1/30 (2006.01); A61K 31/137 (2006.01); A61K 31/155 (2006.01); A61K 31/165 (2006.01); A61K 31/415 (2006.01); A61K 31/4439 (2006.01); A61K 31/473 (2006.01); A61K 31/4965 (2006.01); A61K 31/7072 (2006.01); A61K 31/708 (2006.01); A61K 9/00 (2006.01); A61K 9/70 (2006.01); A61K 31/4468 (2006.01); A61M 39/22 (2006.01); A61K 31/04 (2006.01); A61K 31/13 (2006.01); A61K 31/18 (2006.01); A61K 31/195 (2006.01); A61K 31/198 (2006.01); A61K 31/216 (2006.01); A61K 31/404 (2006.01); A61K 31/405 (2006.01); A61K 31/4168 (2006.01); A61K 31/421 (2006.01); A61K 31/4453 (2006.01); A61K 31/4458 (2006.01); A61K 31/465 (2006.01); A61K 31/485 (2006.01); A61K 31/4985 (2006.01);
U.S. Cl.
CPC ...
A61M 5/14248 (2013.01); A61K 9/0014 (2013.01); A61K 9/7023 (2013.01); A61K 9/7084 (2013.01); A61K 31/04 (2013.01); A61K 31/13 (2013.01); A61K 31/135 (2013.01); A61K 31/137 (2013.01); A61K 31/155 (2013.01); A61K 31/165 (2013.01); A61K 31/17 (2013.01); A61K 31/18 (2013.01); A61K 31/192 (2013.01); A61K 31/195 (2013.01); A61K 31/198 (2013.01); A61K 31/216 (2013.01); A61K 31/27 (2013.01); A61K 31/404 (2013.01); A61K 31/405 (2013.01); A61K 31/415 (2013.01); A61K 31/4164 (2013.01); A61K 31/4168 (2013.01); A61K 31/42 (2013.01); A61K 31/421 (2013.01); A61K 31/428 (2013.01); A61K 31/435 (2013.01); A61K 31/445 (2013.01); A61K 31/4436 (2013.01); A61K 31/4439 (2013.01); A61K 31/4453 (2013.01); A61K 31/4458 (2013.01); A61K 31/4468 (2013.01); A61K 31/465 (2013.01); A61K 31/47 (2013.01); A61K 31/473 (2013.01); A61K 31/485 (2013.01); A61K 31/498 (2013.01); A61K 31/4965 (2013.01); A61K 31/4985 (2013.01); A61K 31/505 (2013.01); A61K 31/55 (2013.01); A61K 31/704 (2013.01); A61K 31/708 (2013.01); A61K 31/7072 (2013.01); A61M 35/00 (2013.01); A61M 37/00 (2013.01); A61M 37/0015 (2013.01); A61M 37/0092 (2013.01); A61M 39/22 (2013.01); A61N 1/30 (2013.01); A61M 2005/14268 (2013.01); A61M 2037/0007 (2013.01); A61M 2037/0023 (2013.01); A61M 2205/3337 (2013.01); A61M 2205/3368 (2013.01); A61M 2205/50 (2013.01); A61M 2205/502 (2013.01); A61M 2205/8206 (2013.01);
Abstract

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible. An automated, pre-programmable transdermal administration system is used to provide pulsed doses of medications, pharmaceuticals, hormones, neuropeptides, anorexigens, pro-drugs, stimulants, nutraceuticals, phytochemicals, phytonutrients, enzymes, antioxidants, essential oils, fatty acids, minerals, vitamins, amino acids, coenzymes, or other physiological active ingredient or precursor. The system can utilize a pump, pressurized reservoir, a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with porous membranes or micro-fabricated structures.


Find Patent Forward Citations

Loading…